Literature DB >> 31622593

Off-label uses of drugs for depression.

Sigrid S Skånland1, Artur Cieślar-Pobuda2.   

Abstract

The prescription of drugs for depression is rising rapidly. One of the reasons for this trend is their many off-label uses. Up to one third of all prescriptions are for non-indicated use, which in addition to drug repurposing includes different dosing or duration than those recommended. In this review, we elaborate on what antidepressants can treat besides depression. The five classes of drugs for depression are introduced, and their mechanisms of action and serious side effects are described. The most common off-label uses of antidepressants are discussed, with a special focus on treating eating disorders, sleep problems, smoking cessation and managing chronic pain. Depression is often a comorbidity when antidepressants are chosen as therapy, but good therapeutic effects have been observed for other conditions also when depression is not involved. Finally, a new type of antidepressant developed from the hallucinogenic "party drug" ketamine is briefly introduced. This recent development suggests that antidepressants will keep playing a central role in medicine for years to come.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressants; Chronic pain; Eating disorders; Off-label; Sleep disorders; Smoking cessation

Mesh:

Substances:

Year:  2019        PMID: 31622593     DOI: 10.1016/j.ejphar.2019.172732

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Serotonin Syndrome/Serotonin Toxicity.

Authors:  Cynthia Wright Talton
Journal:  Fed Pract       Date:  2020-10

2.  Subphenotyping depression using machine learning and electronic health records.

Authors:  Zhenxing Xu; Fei Wang; Prakash Adekkanattu; Budhaditya Bose; Veer Vekaria; Pascal Brandt; Guoqian Jiang; Richard C Kiefer; Yuan Luo; Jennifer A Pacheco; Luke V Rasmussen; Jie Xu; George Alexopoulos; Jyotishman Pathak
Journal:  Learn Health Syst       Date:  2020-08-03

Review 3.  Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?

Authors:  Yaser Pashaei
Journal:  J Clin Neurosci       Date:  2021-03-19       Impact factor: 1.961

Review 4.  Paroxetine-Overview of the Molecular Mechanisms of Action.

Authors:  Magdalena Kowalska; Jacek Nowaczyk; Łukasz Fijałkowski; Alicja Nowaczyk
Journal:  Int J Mol Sci       Date:  2021-02-07       Impact factor: 5.923

5.  Comorbid Chronic Pain and Depression: Shared Risk Factors and Differential Antidepressant Effectiveness.

Authors:  William H Roughan; Adrián I Campos; Luis M García-Marín; Gabriel Cuéllar-Partida; Michelle K Lupton; Ian B Hickie; Sarah E Medland; Naomi R Wray; Enda M Byrne; Trung Thanh Ngo; Nicholas G Martin; Miguel E Rentería
Journal:  Front Psychiatry       Date:  2021-04-12       Impact factor: 4.157

6.  Psychotropic Drug Use in Acute Myeloid Leukaemia (AML) and Myelodysplastic Syndrome (MDS): A Danish Nationwide Matched Cohort Study of 2404 AML and 1307 MDS Patients.

Authors:  Oda Jensen; Andreas Kiesbye Øvlisen; Lasse Hjort Jakobsen; Anne Stidsholt Roug; René Ernst Nielsen; Claus Werenberg Marcher; Lene Hyldahl Ebbesen; Kim Theilgaard-Mönch; Peter Møller; Claudia Schöllkopf; Christian Torp-Pedersen; Tarec Christoffer El-Galaly; Marianne Tang Severinsen
Journal:  Clin Epidemiol       Date:  2022-02-25       Impact factor: 4.790

7.  The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study.

Authors:  Anna Feeney; Rebecca S Hock; Marlene P Freeman; Martina Flynn; Bettina Hoeppner; Dan V Iosifescu; Madhukar H Trivedi; Gerard Sanacora; Sanjay J Mathew; Charles Debattista; Dawn F Ionescu; Maurizio Fava; George I Papakostas
Journal:  Eur Neuropsychopharmacol       Date:  2021-06-03       Impact factor: 5.415

8.  Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study.

Authors:  Sadia Shakeel; Shagufta Nesar; Hina Rehman; Khizra Jamil; Imran Ahsan Mallick; Muhammad Shahid Mustafa; Mudassir Anwar; Shazia Jamshed
Journal:  Pharmacy (Basel)       Date:  2021-12-20

Review 9.  Anesthetic Considerations for Patients on Psychotropic Drug Therapies.

Authors:  Monica W Harbell; Catalina Dumitrascu; Layne Bettini; Soojie Yu; Cameron M Thiele; Veerandra Koyyalamudi
Journal:  Neurol Int       Date:  2021-11-29

Review 10.  Depression and Pain: Use of Antidepressants.

Authors:  Herlinda Bonilla-Jaime; José Armando Sánchez-Salcedo; M Maetzi Estevez-Cabrera; Tania Molina-Jiménez; José Luis Cortes-Altamirano; Alfonso Alfaro-Rodríguez
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.